期刊文献+

头孢特仑新戊酯的合成 被引量:2

Synthesis of cefteram pivoxil
下载PDF
导出
摘要 目的研究头孢特仑新戊酯的合成工艺。方法 7-ACA与5-甲基四氮唑反应制备7-氨基-3-[2-(5-甲基-2H-四氮唑基)甲基]头孢烷酸(7-MTCA),然后与2-(2-氨基-4-噻唑基)-2-甲氧亚胺乙酸苯并噻唑硫酯(AE活性酯)缩合得头孢特仑酸,再与特戊酸碘甲酯反应得产物。结果产品总收率40.8%,质量符合日本药典标准。结论本工艺简单可行,为中试生产提供了依据。 Objective To study the process for synthesis of cefteram pivoxil. Methods The 7-amino-3- [2-(5-methyl-2H-tetrazolyl)methyl]cephalosporanic acid(7-MTCA), obtained by condensation of 7-ACA with 5-methyl-lH-tetrazol, reacted with 2-(2-aminothiazol-4-thiazolyl)-2-[[(z)-methoxy]imino]acetic acid s-mercapto benzothiazolylester(activated ester) to give cefteram. Then cefteram reacted with iodomethyl pivalate to give cefteram pivoxil. Results The overall yield was 40.8% and the product complied with Japanese Pharmacopoeia specification. Conclusion This process was simple and feasible, and it provided a basis for pilot scale production.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2014年第7期507-509,共3页 Chinese Journal of Antibiotics
关键词 头孢特仑新戊酯 7-ACA 5-甲基-1H-四氮唑 合成 Cefteram pivoxil 7-ACA 5-methyl-lH-tetrazol Synthesis
  • 相关文献

参考文献5

  • 1曾晓晖,徐新军,石磊,关慧.头孢特仑新戊酯的药动学和临床评价进展[J].实用药物与临床,2011,14(5):431-434. 被引量:2
  • 2Hiroshi S, Hirokazu N, Hiroyuki I, et al. Cephalosporins: US,4489072[P]. 1984-12-18.
  • 3朱新荣,张连第,丁磊.一类头孢抗生素及其中间体的制备方法:CN,1962666[P].2007-05-16.
  • 4貞木浩,成田弘和,今泉弘之,等.7-置換又非置換アミノ3-置換メチlレセフエムカルボン酸類の新規な製造法: JP, 57?58689[P].1982-04-08.
  • 5Novara L S, Concorezzo D T, Gallarate G R. Process for the preparation of cephalosporins intermediates: US, 5387679[P]. 1995-02-07.

二级参考文献16

  • 1李健华,顾学兰,邹建军.头孢特仑酯药物动力学及生物利用度研究[J].中南药学,2006,4(2):115-118. 被引量:6
  • 2Zou J,Di B,Wu CY,et al.Pharmacokinetic and bioequivalence comparison of a single 100-mg dose of cefteram pivoxil powder suspension and tablet formulations:a randomized-sequence,open-label,two-period crossover study in healthy Chinese adult male volunteers[J].Clin Ther,2008,30(4):654-660.
  • 3Wei F,Zhu R,Zhao W,et al.Pharmacokinetics and bioequivalence studies of cefteram pivoxil in healthy Chinese volunteers[J].Eur J Drug Metab Pharmacokinet,2009,34(3-4):157-162.
  • 4Yamagishi Y,Izumi K,Tanaka K,et al.Evaluation of antimicrobial prophylaxis after normal delivery[J].Jpn J Antibiot,2009,62(2):103-115.
  • 5Matsumoto F,Sakurai I,Morita M,et al.Effects of the quantity of water and milk ingested concomitantly with AS-924,a novel ester-type cephem antibiotic,on its pharmacokinetics[J].Int J Antimicrob Agents,2001,18(5):471-476.
  • 6富山龙(r)市售说明书.http://www.yp900.com/ypsms/sms_192220.htm.
  • 7Saito A,Hiraga Y,Watanabe A,et al.Comparative clinical study of cefcapene pivoxil and cefteram pivoxil in chronic respiratory tract infections by a double-blind method[J].J Int Med Res,2004,32(6):590-607.
  • 8Takenaka M,Morikawa Y,Nakagawa T,et al.Causative organisms of acute otitis media and acute sinusitis in children and their susceptibility of oral beta-lactam antibiotics[J].Jpn J Antibiot,1999,52(2):162-171.
  • 9Shimada J,Saito A,Shiba K,et al.Effects of antacids on absorption,excretion and metabolism of cefteram pivoxil[J].Jpn J Antibiot,1990,43(8):1353-1370.
  • 10Ito T,Sugiyama N,Kobayashi M,et al.Alteration of ammonia and carnitine levels in short-term treatment with pivalic acid-containing prodrug[J].Tohoku J Exp Med,1995,175(1):43-53.

共引文献1

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部